Celldex Therapeutics
CLDX
#4691
Rank
A$2.97 B
Marketcap
A$44.74
Share price
6.44%
Change (1 day)
8.27%
Change (1 year)

Celldex Therapeutics (CLDX) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.98 Billion

According to Celldex Therapeutics's latest financial reports the company's total assets are A$0.98 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celldex Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$1.27 B86.39%
2023-12-31A$0.68 B31.85%
2022-12-31A$0.51 B-15.49%
2021-12-31A$0.61 B99.97%
2020-12-31A$0.30 B74.68%
2019-12-31A$0.17 B-20.61%
2018-12-31A$0.22 B-45.29%
2017-12-31A$0.40 B-23.98%
2016-12-31A$0.53 B14.77%
2015-12-31A$0.46 B52.91%
2014-12-31A$0.30 B-22.12%
2013-12-31A$0.38 B222.11%
2012-12-31A$0.12 B26.4%
2011-12-31A$95.57 M-11.7%
2010-12-31A$0.10 B-30.73%
2009-12-31A$0.15 B57.95%
2008-12-31A$98.92 M822.58%
2007-12-31A$10.72 M-86.25%
2006-12-31A$77.99 M56.55%
2005-12-31A$49.81 M-15.83%
2004-12-31A$59.18 M40.54%
2003-12-31A$42.11 M-32.65%
2002-12-31A$62.53 M-40.33%
2001-12-31A$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Seagen
SGEN
A$5.49 B 460.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.35 B-63.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.20 B 125.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$136.23 B 13,801.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$315.47 B 32,089.77%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.63 B 12,616.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
A$4.61 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA